(Q48463443)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1387635%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

title

ES-242-2, -3, -4, -5, -6, -7, and -8, novel bioxanthracenes produced by Verticillium sp., which act on the N-methyl-D-aspartate receptor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1387635%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1 reference

(3R,4R)-5-[(3R,4S)-4,10-dihydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl]-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromene-4,10-diol

1 reference

[(3R,4S)-5-[(3S,4R)-4-acetyloxy-10-hydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl]-10-hydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-4-yl] acetate

1 reference

(3R)-5-[(3R)-10-hydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl]-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-10-ol

1 reference

(3R,4S)-5-[(3R)-10-hydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl]-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromene-4,10-diol

1 reference

[(3S,4S)-5-[(3S,4R)-4,10-dihydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl]-10-hydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-4-yl] acetate

1 reference

(3S,4R)-6-[(3S)-10-hydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl]-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromene-4,10-diol

1 reference

(3R,4R)-5-[(3S)-10-hydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-6-yl]-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromene-4,10-diol

1 reference

S. Toki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1387635

21 September 2022

K. Ando

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1387635

21 September 2022

I. Kawamoto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1387635

21 September 2022

H. Sano

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1387635

21 September 2022

M. Yoshida

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1387635

21 September 2022

Y. Matsuda

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1387635

21 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1387635

full work available at URL

21 September 2022

publication date

1992

3 references

16 September 2022

16 September 2022

https://www.jstage.jst.go.jp/article/antibiotics1968/45/7/45_7_1047/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.45.1047?email=unpaywall_01@example.com

published in

The Journal of Antibiotics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1387635%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1387635%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1387635%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

page(s)

1047-1054

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1387635%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.45.1047?email=unpaywall_01@example.com

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

cites work

ES-242-1, a novel compound from Verticillium sp., binds to a site on N-methyl-D-aspartate receptor that is coupled to the channel domain

2 references

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.45.88

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.1047

Ketamine and phencyclidine cause a voltage-dependent block of responses to L-aspartic acid.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.1047

[3H]TCP: a new tool with high affinity for the PCP receptor in rat brain.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.1047

Characterization of quisqualate recognition sites in rat brain tissue using DL-[3H]alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and a filtration assay.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.1047

Synthesis and characterization of a series of diarylguanidines that are noncompetitive N-methyl-D-aspartate receptor antagonists with neuroprotective properties

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.1047

Noncompetitive excitatory amino acid receptor antagonists

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.1047

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.45.1047

Identifiers

DOI

10.7164/ANTIBIOTICS.45.1047

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1387635%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1 reference